Oscar Health Files 8-K for Regulation FD Disclosure

Ticker: OSCR · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1568651

Sentiment: neutral

Topics: disclosure, regulation-fd

Related Tickers: OSCR

TL;DR

Oscar Health dropped an 8-K for a Reg FD disclosure. Details TBD.

AI Summary

Oscar Health, Inc. filed an 8-K on June 7, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or details about the nature of the disclosure, only that it is a current report.

Why It Matters

This filing indicates Oscar Health is making a public disclosure under Regulation FD, which requires companies to share material information broadly.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure without immediate financial implications or significant new information.

Key Players & Entities

FAQ

What is the specific nature of the Regulation FD Disclosure being made by Oscar Health, Inc.?

The provided text of the 8-K filing does not specify the content of the Regulation FD Disclosure, only that such a disclosure is being made.

When was this 8-K filing submitted to the SEC?

The filing was submitted on June 7, 2024.

What is Oscar Health, Inc.'s principal executive office address?

The principal executive offices are located at 75 Varick Street, 5th Floor, New York, New York 10013.

What is Oscar Health, Inc.'s telephone number?

The registrant's telephone number is (646) 403-3677.

What is the Commission File Number for Oscar Health, Inc.?

The Commission File Number is 001-40154.

Filing Stats: 930 words · 4 min read · ~3 pages · Grade level 12.9 · Accepted 2024-06-07 06:01:57

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Oscar Health, Inc. By: /s/ Ranmali Bopitiya Name: Ranmali Bopitiya Title: Chief Legal Officer Date: June 7, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing